Journal Summary - Discover more summaries and articles from M3 India - Dermatology

Profile

Close

Journal Summaries

Dermatology

Clinical Pharmacology

Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response

Journal of the European Academy of Dermatology and Venereology | Jan 30, 2018 Clinical Pharmacology

Efficacy and adverse events of oral isotretinoin for acne: A systematic review

British Journal of Dermatology | Jan 26, 2018 Clinical Pharmacology

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: Results of the randomized, double-blind, phase III NAVIGATE trial

British Journal of Dermatology | Jan 26, 2018 Clinical Pharmacology

Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa

Cytokine | Jan 25, 2018 Clinical Pharmacology

Trichloroacetic acid (80%) as a chemical debridement method for chronic venous leg ulcers - A pilot study

International Wound Journal | Jan 25, 2018 Clinical Pharmacology

Neoadjuvant plus adjuvant dabrafenib and trametinib vs standard of care in patients with high-risk, surgically resectable melanoma: A single-centre, open-label, randomised, phase 2 trial

The Lancet Oncology | Jan 24, 2018 Clinical Pharmacology

Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modelling

Arthritis & Rheumatism | Jan 24, 2018 Clinical Pharmacology

A systematic review and meta-analysis of efficacy and safety of novel interleukin inhibitors in the management of psoriatic arthritis

JCR: Journal of Clinical Rheumatology | Evidence based | Jan 24, 2018 Clinical Pharmacology

Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents

Dermatologic Therapy | Jan 23, 2018 Clinical Pharmacology

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Journal of the American Academy of Dermatology | Jan 19, 2018 Clinical Pharmacology

« Prev 1 … 76 77 78 79 80 … 92 Next »

Most read this week

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Home
Quiz
Videos
Menu

Add M3 India to your Home screen

Tap

and select "Add to Home screen" to pin the M3 India App to your Home screen

Okay